Mode
Text Size
Log in / Sign up

Narrative review links chronic stress and HPA dysregulation to cognitive dysfunction in ME/CFSBrain Fog in Chronic Fatigue: A New Clue

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider HPA axis dysregulation as a potential target for cognitive dysfunction in ME/CFS.

This narrative review focuses on patients with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) to evaluate the relationship between chronic stress, HPA axis dysregulation, and cognitive dysfunction. The scope includes secondary outcomes such as attention, memory, concentration, hippocampal structure, neuroinflammatory responses, and neurotransmitter homeostasis. The authors integrate current evidence to discuss potential mechanisms rather than reporting specific trial data or pooled effect sizes.

The text notes that chronic stress has been proposed as an important contributing factor and that dysregulation may be associated with cognitive dysfunction. However, the review does not report specific sample sizes, adverse events, or statistical significance levels. The authors distinguish between association and causation, using terms like 'proposed' and 'may be associated' to reflect the observational nature of the integrated evidence.

Limitations acknowledged include the lack of reported sample sizes and the theoretical nature of the conclusions. The review does not provide absolute numbers, event rates, or confidence intervals. Consequently, the practice relevance is framed as providing a theoretical basis for identifying potential intervention targets and informing strategies centered on HPA axis regulation, rather than offering definitive clinical guidelines.

  • Scientists link brain fog to stress system dysfunction
  • Could help millions with ME/CFS feel more like themselves
  • Still in early stages — not a treatment yet

This discovery may explain why thinking feels so hard for people with chronic fatigue.

You wake up tired, even after 10 hours of sleep. Words slip away mid-sentence. You read the same paragraph three times and still don’t get it. This is daily life for millions with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). Patients often call it “brain fog” — a thick mental haze that won’t lift.

But now, scientists are uncovering what might be driving it.

ME/CFS affects up to 2 million people in the U.S. alone. It’s not just extreme tiredness. Many struggle with thinking, focusing, and remembering — even simple tasks feel overwhelming.

There’s no approved treatment for brain fog. Doctors often suggest pacing or therapy, but these don’t fix the root cause. Patients feel stuck, misunderstood, and dismissed.

Current drugs don’t help much. That’s why finding the source of cognitive symptoms is so urgent.

The Hidden Stress Switch

For years, experts thought brain fog was just from being too tired. But here’s the twist: new research shows the body’s stress system may be stuck in overdrive.

This system is called the HPA axis — think of it like your body’s alarm bell for stress. When it works right, it turns on when needed and shuts off when danger passes.

But in ME/CFS, this alarm may never fully turn off.

What Scientists Didn’t Expect

Chronic stress can throw the HPA axis out of balance. One key sign? Cortisol — the main stress hormone — loses its normal rhythm.

Normally, cortisol peaks in the morning to help you wake up, then drops at night so you can sleep. In ME/CFS, this pattern often flattens.

That matters because cortisol helps regulate brain function. When its rhythm is off, so is thinking.

A Key Link Found

The hippocampus — a small area deep in the brain — is central to memory and focus. It’s also packed with receptors for cortisol.

Too much or too little cortisol over time can damage this region. Think of it like a garden flooded or starved of water — plants can’t grow.

Studies show people with ME/CFS may have changes in hippocampal structure and function. This could directly explain learning and memory problems.

Imagine the hippocampus as a traffic control center for thoughts. It directs signals for memory, focus, and emotion.

But if the HPA axis is broken, it’s like sending too many emergency trucks down one road. The system gets clogged.

This overload may trigger brain inflammation, harm brain cells, and disrupt key chemicals like serotonin and dopamine.

Over time, the brain’s ability to adapt — called plasticity — weakens. That makes recovery harder.

This doesn’t mean this treatment is available yet.

This paper is a review of over 100 studies on ME/CFS, stress, and brain function. It pulls together findings from human trials, brain scans, and lab models.

Researchers focused on how long-term stress affects the HPA axis and hippocampus in ME/CFS patients.

The goal: map out biological pathways that could be targeted for future therapies.

The strongest link? HPA axis dysfunction appears tied to worse cognitive symptoms.

Patients with flatter cortisol rhythms report more severe brain fog. Brain imaging shows reduced hippocampal volume in some cases.

One study found ME/CFS patients scored lower on attention tests — similar to losing 10–15 IQ points during flare-ups.

That’s like going from sharp and clear to struggling with basic decisions.

The Surprising Shift

Earlier theories blamed inactivity or depression for brain fog. But this research suggests biology comes first.

Even patients who rest a lot still have cognitive issues. And antidepressants often don’t help.

That points to a physical root — not just mood or behavior.

But There’s a Catch

Most evidence comes from small studies or animal models. No large trials have tested treatments that fix HPA axis function yet.

Also, not every ME/CFS patient has the same cortisol pattern. Some have low levels, others high — suggesting subtypes may exist.

This complexity means one solution won’t fit all.

Scientists say this review strengthens the case that ME/CFS is a real, biological illness — not laziness or anxiety.

It also highlights the need to treat the body and brain together.

Stress management alone won’t fix a broken system. But regulating the HPA axis could open new paths for care.

Right now, there’s no drug or test based on these findings. You can’t walk into a clinic and get HPA-targeted therapy.

But understanding the biology helps validate patient experiences. It may lead to better diagnostics and treatments down the road.

If you have ME/CFS, talk to your doctor about managing stress — not as a fix, but as part of overall care.

Researchers are exploring drugs and lifestyle strategies that may reset the HPA axis — like low-dose cortisol regulators, mindfulness, or timed light exposure.

Larger clinical trials are needed. It may take years before new treatments arrive.

But for now, this science offers something powerful: hope grounded in biology.

Study Details

Study typeSystematic review
EvidenceLevel 1
PublishedApr 2026
View Original Abstract ↓
Cognitive dysfunction is a common and disabling clinical feature of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), often described by patients as “brain fog.” These symptoms typically manifest as difficulties in attention, memory, and concentration. Chronic stress has been proposed as an important contributing factor in ME/CFS. The hypothalamic-pituitary-adrenal (HPA) axis plays a central role in the stress response, and prolonged adverse stress may contribute to HPA axis dysregulation, including altered cortisol rhythmicity and impaired negative feedback regulation. Such dysregulation may be associated with cognitive dysfunction in ME/CFS through mechanisms involving neuroinflammatory responses, oxidative stress, and disturbances in neurotransmitter homeostasis. Studies suggest that these alterations may affect hippocampal structure and function, thereby contributing to impaired learning and memory processes. As a key brain region involved in cognition and stress regulation, the hippocampus may be implicated in the neurobiological mechanisms underlying cognitive dysfunction in ME/CFS. This review integrates current evidence on the potential role of HPA axis dysregulation and related neurobiological alterations in chronic stress-associated cognitive dysfunction in ME/CFS, with the aim of providing a theoretical basis for identifying potential intervention targets and informing strategies centered on HPA axis regulation.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.